サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1587526

消化管滞留ドラッグデリバリーシステム市場規模、シェア、動向分析レポート：タイプ別、剤形別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

Gastroretentive Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Floating, Expandable), By Dosage (Tablets, Capsule, Gel, Liquid), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
消化管滞留ドラッグデリバリーシステム市場規模、シェア、動向分析レポート：タイプ別、剤形別、流通チャネル別、地域別、セグメント別予測、2025年～2030年
出版日: 2024年10月18日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

消化管滞留ドラッグデリバリーシステム市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の消化管滞留ドラッグデリバリーシステム市場規模は、2025年から2030年にかけて6.4%のCAGRを記録し、2030年までに227億米ドルに達する見込みです。

消化管伸長型ドラッグデリバリーシステム（DDS）は、吸収が上部消化管（GIT）に限定され、効率的に送達できるため、バイオアベイラビリティの低い薬剤に利点をもたらす可能性があります。したがって、絶対的なバイオアベイラビリティを高め、吸収を最大化することが、予測期間中の市場成長を押し上げると予想されます。

これらのDDSのいくつかの利点には、治療効率と薬剤のバイオアベイラビリティの向上が含まれます。制御された体系的なDDSは、疾患部位での薬剤の過剰曝露の可能性を最小限に抑えます。また、体内での薬物代謝が抑制されるため、より高い治療効果が期待できます。したがって、胃内滞留性DDSに関連するさまざまな利点が、市場全体の成長を促進すると予想されます。

DDSは薬物の放出を維持し、小腸や胃での局所療法を可能にします。この方法は、小腸や胃に関連する様々な疾患の治療に有用です。胃や小腸に関連する疾患の増加により、このような効率的なDDSの需要が高まると予想されています。内視鏡センターによると、毎年約6,200万人が消化器疾患と診断されています。ほとんどの消化器系疾患の有病率は年齢とともに増加し、成人や老年人口に新しいヘルスケア・システムの需要を生み出しています。

これらのDDSは、胃の粘膜下組織から深く埋もれたヘリコバクター・ピロリを除去することにより、食道炎を含む十二指腸潰瘍や胃潰瘍の治療に有効です。これとは別に、GRDDSは胃の中でゆっくりと薬を放出し、全身循環中の有効濃度を長時間維持します。したがって、上記の要因によって市場の拡大が予測されます。

消化管滞留ドラッグデリバリーシステム市場レポートハイライト：

  • フローティングドラッグデリバリーシステムが2024年に最大の市場シェアを占めました。
  • これらのシステムは胃液よりも密度が低いため、胃排出速度を変えることなく胃の中で長時間浮遊しています。
  • 液剤型製品タイプは、あらゆるタイプの胃障害の治療において液剤型の胃内滞留性製品が幅広く利用可能であるため、予測期間中に最も速い速度で成長すると予想されます。
  • オンライン薬局セグメントは、詳細な医薬品情報とともに幅広い選択肢を提供しているため、予測期間中に最も速い成長率を示すと予測されています。
  • 北米が最大の市場シェアを占め、予測期間中もその優位性を維持すると予測されています。
  • これは、ピロリ菌感染の有病率の増加、研究開発費の増加、胃透過性DDSの技術的進歩の高まりに起因します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 消化管滞留ドラッグデリバリーシステム市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 消化管滞留ドラッグデリバリーシステム市場：タイプ別ビジネス分析

  • タイプ別市場シェア、2024年と2030年
  • タイプセグメントダッシュボード
  • 市場規模と予測および動向分析、タイプ別、2018～2030年
  • 浮遊性ドラッグデリバリーシステム
  • 拡張可能なドラッグデリバリーシステム
  • 生体接着性ドラッグデリバリーシステム
  • 高密度システム
  • その他

第5章 消化管滞留ドラッグデリバリーシステム市場：剤形別ビジネス分析

  • 剤形市場シェア、2024年および2030年
  • 剤形セグメントダッシュボード
  • 市場規模と予測および動向分析、剤形別、2018～2030年
  • 錠剤
  • カプセル
  • ゲル
  • 液体
  • その他

第6章 消化管滞留ドラッグデリバリーシステム市場：流通チャネル別ビジネス分析

  • 流通チャネル市場シェア、2024年および2030年
  • 流通チャネルセグメントダッシュボード
  • 市場規模と予測および動向分析、流通チャネル別、2018～2030年
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 消化管滞留ドラッグデリバリーシステム市場：タイプ、剤形、流通チャネル別の地域推定・動向分析

  • 地域別市場シェア分析、2024年および2030年
  • 地域市場ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年：
  • 北米
    • 国別、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018年-2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 国別、2018年-2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018年-2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Catalent, Inc
    • Lonza
    • Evonik Industries AG
    • Colorcon
    • Quotient Sciences
    • AptarGroup, Inc.
    • Aenova Holding GmbH
    • Evotec SE
    • Vectura Group Ltd
    • Ashland
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global gastroretentive drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 6 Global gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 North America gastroretentive drug delivery systems market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 10 North America gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 U.S gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 13 U.S Gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 Canada gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 16 Canada gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17 Mexico gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 18 Mexico gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 19 Mexico gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Europe gastroretentive drug delivery systems market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 22 Europe gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 23 Europe gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 UK gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 26 UK Gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 Germany gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 28 Germany gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 29 Germany gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 France gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 31 France gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 32 France Gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 Italy gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 34 Italy gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 35 Italy gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Spain gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 37 Spain gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 38 Spain gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 Norway gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 40 Norway gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 41 Norway Gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Denmark gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 43 Denmark gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 44 Denmark gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Sweden gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 46 Sweden gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 47 Sweden gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific gastroretentive drug delivery systems market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Japan gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 53 Japan gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 54 Japan gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 China gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 56 China gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 57 China gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 India gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 59 India gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 60 India gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Australia gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 62 Australia gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 63 Australia gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 64 South Korea gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 65 South Korea gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 66 South Korea gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 67 Thailand gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 68 Thailand gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 69 Thailand gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 70 Latin America gastroretentive drug delivery systems market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 72 Latin America gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 73 Latin America gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 74 Brazil gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 75 Brazil gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 76 Brazil gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 77 Argentina gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 78 Argentina gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 79 Argentina gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Gastroretentive drug delivery systems market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 84 South Africa gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 85 South Africa gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 86 South Africa gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 90 UAE gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 91 UAE gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 92 UAE gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 93 Kuwait gastroretentive drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait gastroretentive drug delivery systems market, by dosage, 2018 - 2030 (USD Million)
  • Table 95 Kuwait gastroretentive drug delivery systems market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Gastroretentive drug delivery systems market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and dosage outlook (USD Million)
  • Fig. 10 Distribution channel outlook
  • Fig. 11 Competitive landscape
  • Fig. 12 Gastroretentive drug delivery systems market dynamics
  • Fig. 13 Gastroretentive drug delivery systems market: Porter's five forces analysis
  • Fig. 14 Gastroretentive drug delivery systems market: PESTLE analysis
  • Fig. 15 Gastroretentive drug delivery systems market: Type segment dashboard
  • Fig. 16 Gastroretentive drug delivery systems market: Type market share analysis, 2024 & 2030
  • Fig. 17 Floating drug delivery system market, 2018 - 2030 (USD Million)
  • Fig. 18 Expandable drug delivery system market, 2018 - 2030 (USD Million)
  • Fig. 19 Bioadhesive drug delivery system market, 2018 - 2030 (USD Million)
  • Fig. 20 High density systems market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Gastroretentive drug delivery systems market: Dosage segment dashboard
  • Fig. 23 Gastroretentive drug delivery systems market: Dosage market share analysis, 2024 & 2030
  • Fig. 24 Tablets market, 2018 - 2030 (USD Million)
  • Fig. 25 Capsule market, 2018 - 2030 (USD Million)
  • Fig. 26 Gel market, 2018 - 2030 (USD Million)
  • Fig. 27 Liquid market, 2018 - 2030 (USD Million)
  • Fig. 28 Others market, 2018 - 2030 (USD Million)
  • Fig. 29 Gastroretentive drug delivery systems market: Distribution channel segment dashboard
  • Fig. 30 Gastroretentive drug delivery systems market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 31 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 32 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 33 Online pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 34 Gastroretentive drug delivery systems market revenue, by region
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 North America gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. country dynamics
  • Fig. 39 U.S. gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 40 Canada country dynamics
  • Fig. 41 Canada gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico country dynamics
  • Fig. 43 Mexico gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 45 UK country dynamics
  • Fig. 46 UK gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany country dynamics
  • Fig. 48 Germany gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 49 France country dynamics
  • Fig. 50 France gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 51 Italy country dynamics
  • Fig. 52 Italy gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain country dynamics
  • Fig. 54 Spain gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 55 Norway country dynamics
  • Fig. 56 Norway gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden country dynamics
  • Fig. 58 Sweden gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark country dynamics
  • Fig. 60 Denmark gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 62 Japan country dynamics
  • Fig. 63 Japan gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 64 China country dynamics
  • Fig. 65 China gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 66 India country dynamics
  • Fig. 67 India gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 68 Australia country dynamics
  • Fig. 69 Australia gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea country dynamics
  • Fig. 71 South Korea gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand country dynamics
  • Fig. 73 Thailand gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil country dynamics
  • Fig. 76 Brazil gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 77 Argentina country dynamics
  • Fig. 78 Argentina gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 79 MEA gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 80 South Africa country dynamics
  • Fig. 81 South Africa gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia country dynamics
  • Fig. 83 Saudi Arabia gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 84 UAE country dynamics
  • Fig. 85 UAE gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 86 Kuwait country dynamics
  • Fig. 87 Kuwait gastroretentive drug delivery systems market, 2018 - 2030 (USD Million)
  • Fig. 88 Company categorization
  • Fig. 89 Company market position analysis
  • Fig. 90 Strategic framework
目次
Product Code: GVR-4-68039-415-9

Gastroretentive Drug Delivery Systems Market Growth & Trends:

The global gastroretentive drug delivery systems market size is expected to reach USD 22.7 billion by 2030, registering a CAGR of 6.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Gastroretentive Drug Delivery Systems (DDSs) offer possible advantages for the drug with poor bioavailability, as their absorption is restricted to the upper Gastrointestinal Tract (GIT) and can be delivered proficiently. Hence enhancing absolute bioavailability and maximizing its absorption is expected to boost market growth during the forecast period.

Several advantages of these DDSs include curative efficiency and an increase in the bioavailability of drugs. The controlled and systematic DDS minimizes the chances of medicine overexposure at the diseased site. It also offers higher efficiency owing to reduced counter activity by the body. Hence, various advantages associated with gastroretentive DDSs are expected to foster the overall market progression.

The DDS sustains the release of drugs and avails local therapy in the small intestine and stomach. The method is useful in the treatment of various disorders related to the small intestine and stomach. Rising cases of stomach and small intestine-related disorders are anticipated to foster the demand for such efficient DDSs. According to the Endoscopy Center, each year around 62.0 million people are diagnosed with digestive disorders. The prevalence of most digestive disorders increases with age, creating demand for novel healthcare systems among adults and the geriatric population.

These DDSs are effective in treating duodenal and gastric ulcers, including esophagitis, by eliminating deeply buried helicobacter pylori from the submucosal tissue of the stomach. Apart from this, GRDDSs release the medicine slowly in the stomach and preserve its effective concentration in systemic circulation for a prolonged period of time. Hence, the above-mentioned factors are predicted to augment market expansion.

Gastroretentive Drug Delivery Systems Market Report Highlights:

  • The floating drug delivery systems held the largest market share in 2024.
  • These systems have a lower density than gastric fluids and hence stay buoyant in the stomach without altering the gastric emptying rate for a long time.
  • The liquid dosage form segment is expected to grow at the fastest rate during the forecast period due to the availability of a wide range of liquid-based gastroretentive products in treating all types of gastric disorders.
  • The online pharmacies segment is predicted to witness the fastest growth rate over the forecast timeframe as they offer a wide range of options along with in-depth drug information.
  • North America held the largest market share and is anticipated to maintain its dominance over the forecast period.
  • This is attributable to the growing prevalence of H. Pylori infection, increasing R&D expenditure, and rising technological advancements in gastroretentive DDSs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Dosage
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Gastroretentive Drug Delivery Systems Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Gastroretentive Drug Delivery Systems Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Floating Drug Delivery System
    • 4.4.1. Floating Drug Delivery System Market, 2018 - 2030 (USD Million)
  • 4.5. Expandable Drug Delivery System
    • 4.5.1. Expandable Drug Delivery System Market, 2018 - 2030 (USD Million)
  • 4.6. Bioadhesive Drug Delivery System
    • 4.6.1. Bioadhesive Drug Delivery System Market, 2018 - 2030 (USD Million)
  • 4.7. High Density Systems
    • 4.7.1. High Density Systems Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Gastroretentive Drug Delivery Systems Market: Dosage Business Analysis

  • 5.1. Dosage Market Share, 2024 & 2030
  • 5.2. Dosage Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Dosage, 2018 to 2030 (USD Million)
  • 5.4. Tablets
    • 5.4.1. Tablets Market, 2018 - 2030 (USD Million)
  • 5.5. Capsule
    • 5.5.1. Capsule Market, 2018 - 2030 (USD Million)
  • 5.6. Gel
    • 5.6.1. Gel Market, 2018 - 2030 (USD Million)
  • 5.7. Liquid
    • 5.7.1. Liquid Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Gastroretentive Drug Delivery Systems Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 7. Gastroretentive Drug Delivery Systems Market: Regional Estimates & Trend Analysis by Type, Dosage, and Distribution Channel

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Gastroretentive Drug Delivery Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Catalent, Inc
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Lonza
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Evonik Industries AG
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Colorcon
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Quotient Sciences
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. AptarGroup, Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Aenova Holding GmbH
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Evotec SE
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Vectura Group Ltd
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Ashland
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives